© 2020 MJH Life Sciences and OncLive. All rights reserved.
May 19, 2020
Manish Kohli, MD, discusses the use of enzalutamide (Xtandi) and apalutamide (Erleada) in patients with metastatic hormone-sensitive prostate cancer (mHSPC).
May 18, 2020
January 25, 2020
Manish Kohli, MD, discusses drugs that have been evaluated in metastatic castration-resistant prostate cancer.
September 25, 2019
Manish Kohli, MD, discusses the challenges of molecular classification in prostate cancer.